Pregabalin

Product NDC: 71610-871
Requested package NDC: 71610-871-92
11-digit product format: 716100871
Labeler code: 71610
Product ID: 71610-871_29b8f9fb-7384-9fd4-e063-6394a90ad5d9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Pregabalin
Dosage form: CAPSULE
Route: ORAL
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Application: ANDA205321
Marketing category: ANDA
Marketing start: 2023-03-29
Substance: PREGABALIN
Active strength: 100 mg/1
DEA schedule: CV
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 8 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A205321-001	PREGABALIN	PREGABALIN	25MG	CAPSULE / ORAL	AB	2023-03-29
A205321-002	PREGABALIN	PREGABALIN	50MG	CAPSULE / ORAL	AB	2023-03-29
A205321-003	PREGABALIN	PREGABALIN	75MG	CAPSULE / ORAL	AB	2023-03-29
A205321-004	PREGABALIN	PREGABALIN	100MG	CAPSULE / ORAL	AB	2023-03-29
A205321-005	PREGABALIN	PREGABALIN	150MG	CAPSULE / ORAL	AB	2023-03-29
A205321-006	PREGABALIN	PREGABALIN	200MG	CAPSULE / ORAL	AB	2023-03-29
A205321-007	PREGABALIN	PREGABALIN	225MG	CAPSULE / ORAL	AB	2023-03-29
A205321-008	PREGABALIN	PREGABALIN	300MG	CAPSULE / ORAL	AB	2023-03-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 8 matching rows.

Application-product, TE code table
Application-product	TE code
A205321-001	AB
A205321-002	AB
A205321-003	AB
A205321-004	AB
A205321-005	AB
A205321-006	AB
A205321-007	AB
A205321-008	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 200 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A205321-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2023-03-29	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A205321-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2023-03-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A205321-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2023-03-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2023-03-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A205321-001	PREGABALIN	25MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-002	PREGABALIN	50MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-003	PREGABALIN	75MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-004	PREGABALIN	100MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-005	PREGABALIN	150MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-006	PREGABALIN	200MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-007	PREGABALIN	225MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-008	PREGABALIN	300MG	CAPSULE / ORAL	AB	2023-03-29	`6a471c1ec25d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 200 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A205321-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-004	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-005	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-006	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-007	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A205321-008	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A205321-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-006	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-007	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205321-008	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A205321-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-006	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-007	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205321-008	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-006	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-007	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205321-008	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A205321-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-006	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-007	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205321-008	AB	1	`6a471c1ec25d…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Pregabalin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PREGABALIN	100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
55JG375S6M	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
483438	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
29b91992-c853-a57d-e063-6394a90ab365	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
441d8579-bd15-4585-93f4-9de3db2d851d	Product name	4	20251114
004d1029-ec13-fc89-74f4-3907cf5b6602	Product name	2	20140523

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71610-871-30	Pregabalin	30 in 1 BOTTLE	CAPSULE	30	1
71610-871-46	Pregabalin	56 in 1 BOTTLE	CAPSULE	56	1
71610-871-53	Pregabalin	60 in 1 BOTTLE	CAPSULE	60	1
71610-871-92	Pregabalin	270 in 1 BOTTLE	CAPSULE	270	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71610-871-30	EA - Each	71610-871	2a399cd8-2048-4038-94c3-caafed1f9465	1	2025-02-10
71610-871-46	EA - Each	71610-871	15945881-06b3-4dee-a67d-929e307744a2	1	2025-02-10
71610-871-53	EA - Each	71610-871	5fc5cacc-4b26-4a03-a99e-0eaa48896abc	1	2025-02-10
71610-871-92	EA - Each	71610-871	ee41930d-72a0-4dd4-9fc1-140a48b44b6b	1	2025-02-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71610-871	PREGABALIN CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC ]	1	Current NDC, 4 package rows	20241222_29b91992-c853-a57d-e063-6394a90ab365.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Pregabalin	PREGABALIN	Clinical Solutions Wholesale, LLC	93c2fe8b-67d7-4a15-8790-5595e158b3ab	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205321 application number: ANDA205321
Pregabalin	PREGABALIN	Coupler LLC	5383c0de-0c85-f702-e063-6294a90a1d8d	2026-06-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205321 application number: ANDA205321
Pregabalin	PREGABALIN	Aurobindo Pharma Limited	11034861-eef2-4996-8082-afc3c1769171	2026-04-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205321 application number: ANDA205321
Pregabalin	PREGABALIN	Coupler LLC	463d31dd-ff14-cc89-e063-6294a90a2ea9	2026-01-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205321 application number: ANDA205321
Pregabalin	PREGABALIN	Coupler LLC	2ccc641e-6859-046e-e063-6294a90a5017	2025-01-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205321 application number: ANDA205321
Pregabalin	PREGABALIN	Aphena Pharma Solutions - Tennessee, LLC	29b91992-c853-a57d-e063-6394a90ab365	2024-12-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205321 application number: ANDA205321 ndc (package): 71610-871-92 ndc (product): 71610-871 ndc11 (package): 71610087192

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
55JG375S6M	PREGABALIN	148553-50-8	PREGABALIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
483438	pregabalin 100 MG Oral Capsule	PSN	29b91992-c853-a57d-e063-6394a90ab365	1
483438	pregabalin 100 MG Oral Capsule	SCD	29b91992-c853-a57d-e063-6394a90ab365	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
71610-871-92	71610087192	270 CAPSULE in 1 BOTTLE (71610-871-92)	270 capsule	2024-12-18	No	No	Current